Cargando…
SAT-423 Anti-thyroid Drug Response in Graves’ Disease: Predictors of Biochemically Persistent Disease
Introduction: Anti-thyroid Drugs (ATD) have become the most frequently used treatment for Graves’ disease (GD) in the United States. However, the response to this therapy is variable. Factors that predict biochemically responsive vs. biochemically persistent disease remain unknown. Identifying predi...
Autores principales: | El Kawkgi, Omar M, Li, Dingfeng, Vallejo, Sebastian, Lincango, Eddy, Mohan, Sneha, Kohlenberg, Jacob, Giblon, Rachel, Stan, Marius, Brito, Juan P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208722/ http://dx.doi.org/10.1210/jendso/bvaa046.291 |
Ejemplares similares
-
Early Biochemical Response to Antithyroid Drugs in Graves’ Disease: The Role of Initial Dosing
por: El Kawkgi, Omar M, et al.
Publicado: (2021) -
SAT495 Persistent Euthyroid State in a Patient with Biochemical and Imaging Evidence of Graves' Disease
por: Antony, Mc Anto, et al.
Publicado: (2023) -
SAT-476 Alemtuzumab Induced Graves Disease
por: Caputi, Rafael C, et al.
Publicado: (2020) -
SAT489 Grave’s Disease Secondary To Alemtuzumabuse
por: Gong, Michael Shifeng, et al.
Publicado: (2023) -
SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020)